Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 7, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,699	2,963	1,354	1,114	955	905
Market Cap Growth	5.13%	118.80%	21.52%	16.65%	5.51%	-1.30%
Enterprise Value	2,083	3,336	1,273	1,106	968	916
Last Close Price	35.43	61.85	28.02	23.29	20.11	19.29
PE Ratio	11.75	21.54	14.82	17.94	680.90	18.50
Forward PE	8.57	20.77	16.29	16.96	23.74	35.07
PS Ratio	2.37	4.60	2.71	2.55	2.73	2.81
PB Ratio	2.36	4.63	2.56	2.50	2.13	2.12
P/TBV Ratio	17.78	113.41	2.76	2.74	2.64	2.66
P/FCF Ratio	10.01	20.39	20.79	15.80	40.81	4374.08
P/OCF Ratio	8.18	16.15	15.19	11.37	16.68	21.68
PEG Ratio	1.31	1.06	0.86	0.89	0.95	1.40
EV/Sales Ratio	2.88	5.18	2.55	2.53	2.77	2.84
EV/EBITDA Ratio	7.81	14.03	9.63	11.65	27.85	50.72
EV/EBIT Ratio	9.72	16.70	11.85	15.43	73.07	-
EV/FCF Ratio	12.24	22.95	19.55	15.68	41.37	4427.46
Debt / Equity Ratio	0.87	0.98	0.19	0.23	0.15	0.16
Debt / EBITDA Ratio	2.31	2.56	0.75	1.05	1.69	2.94
Debt / FCF Ratio	3.70	4.29	1.57	1.48	2.87	321.86
Asset Turnover	0.47	0.57	0.71	0.67	0.57	0.59
Inventory Turnover	2.83	2.78	2.55	2.51	1.99	2.12
Quick Ratio	2.49	1.65	2.79	2.08	1.53	1.46
Current Ratio	3.43	2.17	3.99	3.06	2.49	2.84
Return on Equity (ROE)	23.85%	23.55%	18.76%	14.16%	0.25%	11.75%
Return on Assets (ROA)	8.67%	11.07%	9.51%	6.88%	1.36%	-0.00%
Return on Capital (ROIC)	10.20%	13.18%	11.37%	8.40%	1.64%	-0.01%
Earnings Yield	9.26%	4.64%	6.75%	5.57%	0.15%	5.41%
FCF Yield	9.99%	4.90%	4.81%	6.33%	2.45%	0.02%
Buyback Yield / Dilution	0.37%	-1.09%	-5.31%	-1.34%	1.57%	-7.57%
Total Shareholder Return	0.37%	-1.09%	-5.31%	-1.34%	1.57%	-7.57%

Source: S&P Capital IQ. Standard template. Financial Sources.